1. Home
  2. IMMP vs DVS Comparison

IMMP vs DVS Comparison

Compare IMMP & DVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$2.76

Market Cap

410.7M

Sector

Health Care

ML Signal

HOLD

DVS

Dolly Varden Silver Corporation

N/A

Current Price

$4.17

Market Cap

446.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMP
DVS
Founded
1987
2011
Country
Australia
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.7M
446.5M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
IMMP
DVS
Price
$2.76
$4.17
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
163.8K
1.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$382.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$2.48
52 Week High
$3.53
$5.93

Technical Indicators

Market Signals
Indicator
IMMP
DVS
Relative Strength Index (RSI) 49.22 39.00
Support Level $2.74 $3.30
Resistance Level $3.24 $5.04
Average True Range (ATR) 0.13 0.25
MACD -0.01 -0.04
Stochastic Oscillator 53.22 0.55

Price Performance

Historical Comparison
IMMP
DVS

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About DVS Dolly Varden Silver Corporation

Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.

Share on Social Networks: